SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-079968
Filing Date
2020-03-20
Accepted
2020-03-20 07:40:33
Documents
6
Period of Report
2020-03-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d886819d8k.htm 8-K 25454
2 EX-5.1 d886819dex51.htm EX-5.1 7942
3 EX-10.1 d886819dex101.htm EX-10.1 251949
4 EX-10.2 d886819dex102.htm EX-10.2 74264
5 EX-99.1 d886819dex991.htm EX-99.1 9678
6 GRAPHIC g886819page01.jpg GRAPHIC 3610
  Complete submission text file 0001193125-20-079968.txt   375631
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Unum Therapeutics Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38443 | Film No.: 20730250
SIC: 2834 Pharmaceutical Preparations